Bridging the Striking Knowledge Gap on Antiplatelets for Patients With Abdominal Aortic Aneurysm: Commentary on the 2024 European Society for Vascular Surgeons Guidelines on Abdominal Aorto-Iliac Artery Aneurysm Management
Evaluation of the Value of Histological Examination for the Prediction of Genetic Thoracic Proximal Aortopathies
Vascular Registries Contributing to VASCUNET Collaborative Abdominal Aortic Aneurysm Outcome Projects: A Scoping Review
Recommendations for the specialist further training of nursing personnel on intensive care units in the treatment of abdominal aortic aneurysms: results of a modified Delphi procedure with experts
Short Term Outcomes and Treatment Intensity of Major Cardiovascular Emergencies During the SARS-CoV2 Pandemic in Germany
Screening for Peripheral Vascular Stiffness in Lipedema Patients by Automatic Electrocardiogram-Based Oscillometric Detection
Outcomes Following Intact and Ruptured Aneurysm Repair across Nations: Analysis of International Registries Data from the VASCUNET Collaboration 2014 – 2019
Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study
Behandlung der chronischen peripheren arteriellen Verschlusskrankheit (pAVK): Indikationsstellung, etagenspezifische Therapie und Follow-up-Regime
Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study
Prevalence of Genetic Variants and Deep Phenotyping in Patients with Thoracic Aortic Aneurysm and Dissection: A Cross-Sectional Single-Centre Cohort Study
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma.
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial
Prevalence of Genetic Variants and Deep Phenotyping in Patients with Thoracic Aortic Aneurysm and Dissection: A Cross-Sectional Single-Centre Cohort Study
Neue europäische Leitlinie zur asymptomatischen peripheren arteriellen Verschlusskrankheit (PAVK) und Claudicatio intermittens
Antiplatelet Therapy in Patients With Abdominal Aortic Aneurysm Without Symptomatic Atherosclerotic Disease